Gland Pharma Limited (BOM:543245)

India · Delayed Price · Currency is INR

2,313.30

+6.55 (0.28%)

At close: May 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	64.31B	56.17B	56.65B	36.25B	44.01B
Pharmaceuticals Growth	14.50%	-0.85%	56.29%	-17.64%	27.08%
Total	64.31B	56.17B	56.65B	36.25B	44.01B
Total Growth	14.50%	-0.85%	56.29%	-17.64%	27.08%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
USA	34.21B	27.40B	26.88B	20.91B	23.33B
USA Growth	24.85%	1.95%	28.54%	-10.36%	9.61%
Europe	14.04B	10.23B	10.53B	1.87B	2.40B
Europe Growth	37.26%	-2.88%	462.62%	-21.97%	59.06%
Canada, Australia and New Zealand	2.27B	-	-	-	-
India	2.67B	4.77B	5.88B	5.55B	8.80B
India Growth	-43.93%	-18.95%	5.97%	-36.96%	58.17%
Rest of World (ROW)	11.12B	11.38B	11.82B	6.89B	8.48B
Rest of World (ROW) Growth	-2.29%	-3.72%	71.43%	-18.73%	55.46%
Canada	-	1.57B	890.27M	794.90M	829.19M
Canada Growth	-	76.83%	12.00%	-4.14%	25.74%
Australia	-	742.94M	626.45M	218.24M	170.87M
Australia Growth	-	18.60%	187.05%	27.72%	6.54%
New Zealand	-	77.23M	28.17M	10.86M	-
New Zealand Growth	-	174.16%	159.39%	-	-
Total	64.31B	56.17B	56.65B	36.25B	44.01B
Total Growth	14.50%	-0.85%	56.29%	-17.64%	27.08%

Source: S&P Global Market Intelligence.